- Home
- PRIM vs ZLAB Comparison
PRIM vs ZLAB Comparison
Compare PRIM & ZLAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRIM
- ZLAB
- Stock Information
- Founded
- PRIM 1960
- ZLAB 2013
- Country
- PRIM United States
- ZLAB China
- Employees
- PRIM N/A
- ZLAB N/A
- Industry
- PRIM Water Sewer Pipeline Comm & Power Line Construction
- ZLAB Biotechnology: Pharmaceutical Preparations
- Sector
- PRIM Industrials
- ZLAB Health Care
- Exchange
- PRIM Nasdaq
- ZLAB Nasdaq
- Market Cap
- PRIM 4.2B
- ZLAB 4.0B
- IPO Year
- PRIM N/A
- ZLAB 2017
- Fundamental
- Price
- PRIM $111.88
- ZLAB $35.73
- Analyst Decision
- PRIM Strong Buy
- ZLAB Buy
- Analyst Count
- PRIM 10
- ZLAB 6
- Target Price
- PRIM $99.30
- ZLAB $57.22
- AVG Volume (30 Days)
- PRIM 1.0M
- ZLAB 755.3K
- Earning Date
- PRIM 08-04-2025
- ZLAB 08-07-2025
- Dividend Yield
- PRIM 0.29%
- ZLAB N/A
- EPS Growth
- PRIM 55.06
- ZLAB N/A
- EPS
- PRIM 4.40
- ZLAB N/A
- Revenue
- PRIM $6,929,274,000.00
- ZLAB $427,799,000.00
- Revenue This Year
- PRIM $8.99
- ZLAB $45.16
- Revenue Next Year
- PRIM $5.61
- ZLAB $56.81
- P/E Ratio
- PRIM $25.44
- ZLAB N/A
- Revenue Growth
- PRIM 15.08
- ZLAB 32.56
- 52 Week Low
- PRIM $48.34
- ZLAB $16.03
- 52 Week High
- PRIM $115.99
- ZLAB $44.34
- Technical
- Relative Strength Index (RSI)
- PRIM 75.67
- ZLAB 48.57
- Support Level
- PRIM $109.62
- ZLAB $34.37
- Resistance Level
- PRIM $115.99
- ZLAB $35.83
- Average True Range (ATR)
- PRIM 4.30
- ZLAB 1.13
- MACD
- PRIM 0.78
- ZLAB -0.32
- Stochastic Oscillator
- PRIM 85.69
- ZLAB 31.88
About PRIM Primoris Services Corporation
Primoris Services Corp is a provider of infrastructure services operating mainly in the United States and Canada. It provides a wide range of construction services, maintenance, replacement, fabrication and engineering services to a diversified base of customers. The reportable segments are the Utilities segment and the Energy segment. The Utilities segment operates in a range of services, including the installation and maintenance of new and existing natural gas and electric utility distribution and transmission systems, and communication systems. The Energy segment operates in a range of services that include engineering, procurement, and construction, retrofits, highway and bridge construction, demolition, site work, outages, pipeline construction and maintenance, and others.
About ZLAB Zai Lab Limited
Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-1218 (CCR8) Solid Tumors, ZL-1310 (DLL3 ADC) ES-SCLC Other NECs, ZL-6301 (ROR1 ADC) Solid Tumors, ZL 6201 (LRRC15 ADC) Solid Tumors.